DK1362045T3 - 2-Thio-substituerede imidazolderivater og deres anvendelse inden for farmacien - Google Patents
2-Thio-substituerede imidazolderivater og deres anvendelse inden for farmacienInfo
- Publication number
- DK1362045T3 DK1362045T3 DK02716791T DK02716791T DK1362045T3 DK 1362045 T3 DK1362045 T3 DK 1362045T3 DK 02716791 T DK02716791 T DK 02716791T DK 02716791 T DK02716791 T DK 02716791T DK 1362045 T3 DK1362045 T3 DK 1362045T3
- Authority
- DK
- Denmark
- Prior art keywords
- sub
- thio
- imidazole derivatives
- substituted imidazole
- pharmaceutical industry
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Communicable Diseases (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10107683A DE10107683A1 (de) | 2001-02-19 | 2001-02-19 | 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie |
PCT/EP2002/001746 WO2002066458A2 (de) | 2001-02-19 | 2002-02-19 | 2-thio-substituierte imidazolderivate und ihre verwendung in der pharmazie |
EP02716791A EP1362045B1 (de) | 2001-02-19 | 2002-02-19 | 2-thio-subsituierte imidazolderivative und ihre verwendung in der pharmazie |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1362045T3 true DK1362045T3 (da) | 2005-03-29 |
Family
ID=7674545
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK02716791T DK1362045T3 (da) | 2001-02-19 | 2002-02-19 | 2-Thio-substituerede imidazolderivater og deres anvendelse inden for farmacien |
Country Status (23)
Country | Link |
---|---|
US (1) | US7253191B2 (xx) |
EP (1) | EP1362045B1 (xx) |
JP (1) | JP2004521913A (xx) |
KR (1) | KR100642231B1 (xx) |
CN (1) | CN1291984C (xx) |
AT (1) | ATE282605T1 (xx) |
AU (1) | AU2002247726C1 (xx) |
BR (1) | BR0207254A (xx) |
CA (1) | CA2453078A1 (xx) |
CZ (1) | CZ20032224A3 (xx) |
DE (2) | DE10107683A1 (xx) |
DK (1) | DK1362045T3 (xx) |
ES (1) | ES2233808T3 (xx) |
HK (1) | HK1056725A1 (xx) |
HU (1) | HUP0303155A3 (xx) |
IL (1) | IL157050A0 (xx) |
IS (1) | IS6914A (xx) |
MX (1) | MXPA03007380A (xx) |
PL (1) | PL367397A1 (xx) |
PT (1) | PT1362045E (xx) |
RU (1) | RU2284326C2 (xx) |
SK (1) | SK10242003A3 (xx) |
WO (1) | WO2002066458A2 (xx) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10107683A1 (de) | 2001-02-19 | 2002-08-29 | Merckle Gmbh Chem Pharm Fabrik | 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie |
DE10222103A1 (de) * | 2002-05-17 | 2003-11-27 | Merckle Gmbh Chem Pharm Fabrik | 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie |
DE10238045A1 (de) | 2002-08-20 | 2004-03-04 | Merckle Gmbh Chem.-Pharm. Fabrik | 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie |
DE10256881A1 (de) * | 2002-12-05 | 2004-06-24 | Beiersdorf Ag | Neue topische Verwendung von Bis-Arylimidazo[1,2-a]thiolanderivaten |
DE602005010577D1 (de) | 2004-05-26 | 2008-12-04 | Janssen Pharmaceutica Nv | Mercaptoimidazole als ccr2-rezeptorantagonisten |
EP1753758B1 (en) | 2004-05-26 | 2009-03-11 | Janssen Pharmaceutica N.V. | Mercaptoimidazoles as ccr2 receptor antagonists |
CA2573066A1 (en) * | 2004-08-11 | 2006-02-16 | Janssen Pharmaceutica N.V. | Mercaptoimidazoles as ccr2 receptor antagonists |
WO2006089798A1 (en) * | 2005-02-28 | 2006-08-31 | Merckle Gmbh | 2-sulfinyl- and 2-sulfonyl-substituted imidazole derivatives and their use as cytokine inhibitors |
EP1894925A1 (en) * | 2006-08-24 | 2008-03-05 | Merckle Gmbh | Imidazole compounds having an antiinflammatory effect |
WO2008085008A1 (en) * | 2007-01-11 | 2008-07-17 | Mogam Biotechnology Research Institute | T-cell inhibiting compounds and their use for the treatment of t-cell-mediated diseases |
US8143294B2 (en) * | 2007-12-31 | 2012-03-27 | Michael Burnet | 2-sulfanyl-substituted imidazole derivatives and their use as cytokine inhibitors |
CN102249992A (zh) * | 2011-07-05 | 2011-11-23 | 广东工业大学 | 一种制备2-氨基异烟酸的方法 |
DE102013102069A1 (de) | 2013-03-01 | 2014-09-04 | Fsp Fluid Systems Partners Holding Ag | Proportional-Wegeventil sowie hydraulische Schaltung und hydropneumatisches Federungssystem mit einem derartigen Ventil |
US20190060286A1 (en) | 2016-02-29 | 2019-02-28 | University Of Florida Research Foundation, Incorpo | Chemotherapeutic Methods |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1155580A (en) * | 1965-10-21 | 1969-06-18 | Geigy Ag J R | New Imidazole Derivatives their Production and Use |
US4190666A (en) * | 1975-08-11 | 1980-02-26 | E. I. Du Pont De Nemours And Company | Anti-inflammatory 4,5-diarly-2-(substituted-thio)imidazoles and their corresponding sulfoxides and sulfones |
DK16778A (da) | 1977-02-09 | 1978-08-10 | Du Pont | Imidazolderivater deres anvendelser og fremstilling |
CY1302A (en) * | 1978-04-11 | 1985-12-06 | Ciba Geigy Ag | Mercapto-imidazole derivatives,their preparation,their pharmaceutical compositions and applications |
DE2823197A1 (de) | 1978-05-24 | 1979-11-29 | Schering Ag | Neue imidazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate |
DE3025484A1 (de) * | 1980-07-03 | 1982-02-04 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Neue imidazol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate |
DE3141063A1 (de) * | 1981-10-13 | 1983-04-28 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Neue imidazol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate |
DE3504678A1 (de) | 1985-02-12 | 1986-08-14 | A. Nattermann & Cie GmbH, 5000 Köln | Neue imidazolyl-oxyalkansaeuren und -thioalkansaeuren, ihre derivate und verfahren zu ihrer herstellung |
US4686231A (en) | 1985-12-12 | 1987-08-11 | Smithkline Beckman Corporation | Inhibition of 5-lipoxygenase products |
JPS6440467A (en) | 1987-08-04 | 1989-02-10 | Hisamitsu Pharmaceutical Co | Novel substituted diphenylimidazole derivative |
FR2626691B1 (fr) | 1988-02-02 | 1990-05-25 | France Etat | Multiplieur numerique generalise et filtre numerique mettant en oeuvre ce multiplieur |
CA2073443A1 (en) | 1990-01-12 | 1991-07-13 | Andrew William Bridge | 2-substituted 4,5-diphenyl-imidazoles |
IL104369A0 (en) * | 1992-01-13 | 1993-05-13 | Smithkline Beecham Corp | Novel compounds and compositions |
US5364875A (en) * | 1992-05-11 | 1994-11-15 | The Du Pont Merck Pharmaceutical Company | Imidazoles linked to bicyclic heterocyclic groups for the treatment of atherosclerosis |
US5474995A (en) | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
ZA945363B (en) | 1993-07-21 | 1995-03-14 | Smithkline Beecham Corp | Novel compounds |
US5620999A (en) | 1994-07-28 | 1997-04-15 | Weier; Richard M. | Benzenesulfonamide subtituted imidazolyl compounds for the treatment of inflammation |
JP2002515915A (ja) * | 1997-06-30 | 2002-05-28 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | 炎症性疾患の治療で有用な2−置換イミダゾール類 |
DE19842833B4 (de) * | 1998-09-18 | 2005-04-14 | Merckle Gmbh | 2-Arylalkylthio-imidazole, 2-Arylalkenylthio-imidazole und 2-Arylalkinylthio-imidazole als Entzündungs-Hemmstoffe und Hemmstoffe der Cytokin-Freisetzung |
DE10107683A1 (de) | 2001-02-19 | 2002-08-29 | Merckle Gmbh Chem Pharm Fabrik | 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie |
-
2001
- 2001-02-19 DE DE10107683A patent/DE10107683A1/de not_active Withdrawn
-
2002
- 2002-02-19 HU HU0303155A patent/HUP0303155A3/hu unknown
- 2002-02-19 PT PT02716791T patent/PT1362045E/pt unknown
- 2002-02-19 EP EP02716791A patent/EP1362045B1/de not_active Expired - Lifetime
- 2002-02-19 WO PCT/EP2002/001746 patent/WO2002066458A2/de active IP Right Grant
- 2002-02-19 MX MXPA03007380A patent/MXPA03007380A/es active IP Right Grant
- 2002-02-19 US US10/467,064 patent/US7253191B2/en not_active Expired - Fee Related
- 2002-02-19 RU RU2003128068/04A patent/RU2284326C2/ru not_active IP Right Cessation
- 2002-02-19 BR BR0207254-8A patent/BR0207254A/pt not_active IP Right Cessation
- 2002-02-19 AU AU2002247726A patent/AU2002247726C1/en not_active Ceased
- 2002-02-19 JP JP2002565973A patent/JP2004521913A/ja active Pending
- 2002-02-19 SK SK1024-2003A patent/SK10242003A3/sk not_active Application Discontinuation
- 2002-02-19 CN CNB028051548A patent/CN1291984C/zh not_active Expired - Fee Related
- 2002-02-19 DK DK02716791T patent/DK1362045T3/da active
- 2002-02-19 ES ES02716791T patent/ES2233808T3/es not_active Expired - Lifetime
- 2002-02-19 DE DE50201565T patent/DE50201565D1/de not_active Expired - Lifetime
- 2002-02-19 CA CA002453078A patent/CA2453078A1/en not_active Abandoned
- 2002-02-19 CZ CZ20032224A patent/CZ20032224A3/cs unknown
- 2002-02-19 IL IL15705002A patent/IL157050A0/xx unknown
- 2002-02-19 KR KR1020037010839A patent/KR100642231B1/ko not_active IP Right Cessation
- 2002-02-19 PL PL02367397A patent/PL367397A1/xx not_active Application Discontinuation
- 2002-02-19 AT AT02716791T patent/ATE282605T1/de not_active IP Right Cessation
-
2003
- 2003-08-15 IS IS6914A patent/IS6914A/is unknown
- 2003-12-11 HK HK03109068A patent/HK1056725A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1362045B1 (de) | 2004-11-17 |
US7253191B2 (en) | 2007-08-07 |
CN1291984C (zh) | 2006-12-27 |
IS6914A (is) | 2003-08-15 |
DE50201565D1 (de) | 2004-12-23 |
JP2004521913A (ja) | 2004-07-22 |
AU2002247726B2 (en) | 2006-01-19 |
WO2002066458A2 (de) | 2002-08-29 |
MXPA03007380A (es) | 2004-03-16 |
AU2002247726C1 (en) | 2006-08-17 |
IL157050A0 (en) | 2004-02-08 |
KR20030082940A (ko) | 2003-10-23 |
HUP0303155A3 (en) | 2007-08-28 |
RU2284326C2 (ru) | 2006-09-27 |
US20040116416A1 (en) | 2004-06-17 |
CZ20032224A3 (en) | 2004-06-16 |
CA2453078A1 (en) | 2002-08-29 |
CN1511149A (zh) | 2004-07-07 |
PT1362045E (pt) | 2005-04-29 |
PL367397A1 (en) | 2005-02-21 |
RU2003128068A (ru) | 2005-01-27 |
WO2002066458A3 (de) | 2002-12-12 |
ATE282605T1 (de) | 2004-12-15 |
EP1362045A2 (de) | 2003-11-19 |
HUP0303155A2 (hu) | 2003-12-29 |
BR0207254A (pt) | 2004-02-10 |
HK1056725A1 (en) | 2004-02-27 |
SK10242003A3 (sk) | 2004-03-02 |
ES2233808T3 (es) | 2005-06-16 |
KR100642231B1 (ko) | 2006-11-02 |
DE10107683A1 (de) | 2002-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1480961T3 (da) | Glutaminylbaserede DPIV-inhibitorer | |
CY1109006T1 (el) | Παραγωγα πουρινης ως αναστολεις κινασης | |
MY129328A (en) | Triamide-substituted heterobicyclic compounds | |
DK1420801T3 (da) | Anvendelse af fucaner til behandling af adhæsioner, arthritis og psoreasis | |
BR0109703A (pt) | Derivados de piperazina | |
NO20021379L (no) | Benzodiazepin-derivater, fremstilling og anvendelse derav | |
NO20003233D0 (no) | 4-hydrokykinolin-3-karboksamider og hydraziner som antivirale midler | |
YU84603A (sh) | Novi inhibitori tirozin kinaze | |
DK1200418T3 (da) | Nematodicide trifluorbutener | |
BRPI0307351B8 (pt) | composto, composição farmacêutica, uso de um composto, e, processo para preparar um composto | |
ATE372767T1 (de) | Dpp-iv-hemmer | |
DE60003863D1 (de) | Dioxocyclopentylhydroxamsäure | |
DK1362045T3 (da) | 2-Thio-substituerede imidazolderivater og deres anvendelse inden for farmacien | |
WO2004030620A3 (en) | Novel tyrosine kinase inhibitors | |
NO20043016L (no) | 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav | |
ATE501128T1 (de) | 1,2,3-triazolamidderivate als inhibitoren der cytokinproduktion | |
NO20040604L (no) | Trisykliske imidazolpyridiner | |
CY1109950T1 (el) | Νεα παραγωγα 4,4-διθειοδις-(3-αμινοβουτανιο-1-σουλφονικων) και συνθεσεις που τα περιεχουν | |
ATE417856T1 (de) | Motilidverbindungen | |
MXPA05004273A (es) | Derivados de fenilalquil y piridilalquil piperazina. | |
ATE359283T1 (de) | Substituierte pyrazinonverbindungen zur behandlung von entzündungen | |
DE60204882D1 (de) | Zykloalkenylsulfonamidderivate | |
CY1110796T1 (el) | Παραγωγα μορφολινης ως αναστολεις επαναπροσληψης νορεπινεφρινης | |
PT1294729E (pt) | 2-aminoalquil-tieno[2,3-d]pirimidinas | |
RS20050131A (xx) | 2-tio-supstituisani derivati imidazola i njihova primena u farmaciji |